NovaBridge Biosciences (NBP)
1.02
-0.05
(-4.67%)
USD |
NASDAQ |
Nov 03, 14:20
NovaBridge Biosciences Shareholders Equity (Quarterly) : 230.94M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 230.94M |
| September 30, 2025 | 258.92M |
| June 30, 2025 | 196.74M |
| March 31, 2025 | 198.34M |
| December 31, 2020 | 860.45M |
| Date | Value |
|---|---|
| September 30, 2020 | 549.38M |
| December 31, 2019 | -292.10M |
| September 30, 2019 | 180.71M |
| December 31, 2018 | -139.11M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Xencor, Inc. | 503.23M |
| Arrivent BioPharma, Inc. | 366.84M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 3.604B |
| Anika Therapeutics, Inc. | 137.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 260.52M |
| Total Liabilities (Quarterly) | 29.58M |